[Hemolytic uremic syndrome in children]

Arch Pediatr. 2015 May;22(5 Suppl 1):32-3. doi: 10.1016/S0929-693X(15)30017-8.

[Article in French]

Authors

S Cloarec¹, L Prat², E Merieau², S Benoit², J-M Halimi²

Affiliations

¹ Centre de compétence maladies rénales rares, Service de Néphrologie Pédiatrique, CHRU Clocheville, 49 Bd Béranger, 37000 Tours, France. Electronic address: s.cloarec@chu-tours.fr.
² Centre de compétence maladies rénales rares, Service de Néphrologie Pédiatrique, CHRU Clocheville, 49 Bd Béranger, 37000 Tours, France.

PMID: 26112508
DOI: 10.1016/S0929-693X(15)30017-8

No abstract available

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use
Child
Hemolytic-Uremic Syndrome / diagnosis*
Hemolytic-Uremic Syndrome / drug therapy
Hemolytic-Uremic Syndrome / etiology
Humans
Prognosis

Substances

Antibodies, Monoclonal, Humanized
eculizumab